Symbion Health Limited - completed acquisition of non-histopathology assets of Nexus Pathology
Type of assessment
Informal Review
Reference
35059
Acquirer(s)
Symbion Health Limited
Target(s)
Nexus Pathology
Industry
Health
Summary
Symbion Health Limited has acquired the non-histopathology assets of Nexus Pathology.
Outcome of assessment
Not opposed
Total review days *
10
Commenced public review
27th May 2009
Date completed
10th June 2009
Market definition
The ACCC considered the completed acquisition in the context of the market for community pathology services in Queensland.
Competition analysis
The ACCC formed the view that the completed acquisition was unlikely to substantially lessen competition in the relevant market due to the small increase in Symbion's market share and the existence of a number of competing suppliers which would continue to constrain the merged firm.
Review timeline
Date
Event
10th March 2009
The acquisition was completed.
27th May 2009
ACCC commenced review under the Merger Review Process Guidelines.
5th June 2009
Closing date for submissions from interested parties.
10th June 2009
ACCC announced it would not oppose the completed acquisition.
* Total Review days = Total business days less public holidays and time during which the review was suspended.
